Credentials
Positions
- Clinical Assistant Professor, Department of Medicine at NYU Grossman School of Medicine
Education and Training
- Fellowship, Maimonides Medical Center, Hematology Oncology, 2022
- Residency, Montefiore Medical Center, 2019
- MD from Yale University, 2016
Is this your profile?
Edit profileInsurance Plans Accepted
Please call the office for information about accepted insurance plans.
Jason E. Sandler, MD does not accept insurance.
Clinical Trials and Research Studies
-
The purpose of this study is to assess the efficacy and safety of tiragolumab an anti-TIGIT monoclonal antibody when administered in combination with atezolizumab and bevacizumab as first-line treatment in participants with unresectable locally advanc
-
EMBER-4 is a Phase 3 global randomized open-label study of adjuvant imlunestrant vs SOC adjuvant ET of physician s choice in participants who have previously received 2 to 5 years of standard ET for ER+ HER2- EBC (Stages I-III) with an increased risk o
-
A global study to assess the efficacy and tolerability of rilvegostomig compared to placebo in combination with investigator's choice of chemotherapy in participants with BTC after surgical resection with curative intent.
Publications
-
Sukrithan, Vineeth; Sandler, Jason; Gucalp, Rasim; Gralla, Richard; Halmos, Balázs
Clinical lung cancer. 2019 05 ; 20(3):e242-e246
-
Sandler, Jason E; D'Aiello, Angelica; Halmos, Balazs
Journal of thoracic disease. 2019 May ; 11(5):2117-2125
-
Sandler, Jason E; Huang, Huang; Zhao, Nan; Wu, Weiwei; Liu, Fangfang; Ma, Shuangge; Udelsman, Robert; Zhang, Yawei
Cancer epidemiology biomarkers & prevention. 2018 03 ; 27(3):285-294